Metastatic colorectal carcinoma patients: The Glasgow prognostic score (GPS) at the era of anti-VEGF therapies

被引：0

作者：

Maillet, M. ^{[1
]}

Dreanic, J. ^{[1
]}

Dhooge, M. ^{[1
]}

Cessot, A. ^{[1
]}

Mir, O. ^{[1
]}

Brezault, C. ^{[1
]}

Goldwasser, F. ^{[1
]}

Chaussade, S. ^{[1
]}

Coriat, R. ^{[1
]}

机构：

[1] Hop Cochin, F-75674 Paris, France

来源：

EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2291

引用

页码：S526 / S526

页数：1

共 50 条

[41] Prognostic Significance of the Modified Glasgow Prognostic Score in Patients Undergoing FOLFOXIRI plus Bevacizumab Therapy for Advanced or Metastatic Colorectal Cancer [J].

Numata, Koji ;

Ono, Yukari ;

Iguchi, Kenta ;

Uchiyama, Mamoru ;

Asari, Masahiro ;

Kazama, Keisuke ;

Yukawa, Norio ;

Saito, Aya ;

Shiozawa, Manabu .

ONCOLOGY, 2025,

[42] Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients [J].

Choi, Kyeong Woon ;

Hong, Seong Woo ;

Chang, Yeo Goo ;

Lee, Woo Yong ;

Lee, Byungmo ;

Paik, In Wook ;

Lee, Hyucksang .

ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2014, 86 (06) :309-313

[43] Glasgow Prognostic Score as a Prognostic Factor in Patients Undergoing Curative Surgery for Colorectal Cancer [J].

Sugimoto, Kiichi ;

Komiyama, Hiromitsu ;

Kojima, Yutaka ;

Goto, Michitoshi ;

Tomiki, Yuichi ;

Sakamoto, Kazuhiro .

DIGESTIVE SURGERY, 2012, 29 (06) :503-509

[44] Value of the Glasgow Prognostic Score (GPS) in the prognosis of hospitalised patients with gastrointestinal cancer [J].

Pena, J. ;

Rueda-Lara, A. ;

Martin-Montalvo, G. ;

Alameda, M. ;

Jimenez-Bou, D. ;

Ruiz-Gutierrez, I. ;

Marcano, R. ;

Garcia-Leal, A. ;

Zwisler Contreras, P. ;

Martinez Perez, D. ;

Vinal, D. ;

Perez-Wert, J. ;

Custodio, A. ;

Ghanem, I. ;

Rodriguez-Salas, N. ;

Feliu, J. ;

Ruiz-Gimenez, L. ;

Sanchez, D. .

ANNALS OF ONCOLOGY, 2023, 34 :S109-S109

[45] The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer [J].

Gioulbasanis, Ioannis ;

Pallis, Athanasios ;

Vlachostergios, Panagiotis J. ;

Xyrafas, Alexandros ;

Giannousi, Zoe ;

Perdikouri, Isidora-Eleni ;

Makridou, Michalitsa ;

Kakalou, Dionysia ;

Georgoulias, Vassilios .

LUNG CANCER, 2012, 77 (02) :383-388

[46] Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma [J].

Roncone, Daniel ;

Satoskar, Anjali ;

Nadasdy, Tibor ;

Monk, J. Paul ;

Rovin, Brad H. .

NATURE CLINICAL PRACTICE NEPHROLOGY, 2007, 3 (05) :287-293

[47] Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma [J].

Daniel Roncone ;

Anjali Satoskar ;

Tibor Nadasdy ;

J Paul Monk ;

Brad H Rovin .

Nature Clinical Practice Nephrology, 2007, 3 :287-293

[48] Impact of anti-VEGF therapy in metastatic colorectal cancer with an intact primary tumour. [J].

Lee, Belinda ;

Wong, Hui-Li ;

Tie, Jeanne ;

Wong, Rachel ;

Lee, Margaret ;

Nott, Louise M. ;

Shapiro, Jeremy David ;

Jennens, Ross ;

Turner, Natalie Heather ;

Ben Tran ;

Ananda, Sumitra ;

Yip, Desmond ;

Richardson, Gary Edward ;

Parente, Phillip ;

Lim, Lionel ;

Stefanou, Greg ;

Burge, Matthew E. ;

Iddawela, Mahesh Y. ;

Gibbs, Peter .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)

[49] Metastatic Colorectal Cancer Second-line Therapy with anti-VEGF (R) Concept [J].

Eimer, Martina .

ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (12) :793-793

[50] Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer [J].

Schiffmann, Lars Mortimer ;

Fritsch, Melanie ;

Gebauer, Florian ;

Guenther, Saskia Diana ;

Stair, Neil Richard ;

Seeger, Jens Michael ;

Thangarajah, Fabinshy ;

Dieplinger, Georg ;

Bludau, Marc ;

Alakus, Hakan ;

Gobel, Heike ;

Quaas, Alexander ;

Zander, Thomas ;

Hilberg, Frank ;

Bruns, Christiane Josephine ;

Kashkar, Hamid ;

Coutelle, Oliver .

BRITISH JOURNAL OF CANCER, 2019, 120 (01) :69-78

← 1 2 3 4 5 →